458 related articles for article (PubMed ID: 21036514)
1. Outpatient versus inpatient opioid detoxification: a randomized controlled trial.
Day E; Strang J
J Subst Abuse Treat; 2011 Jan; 40(1):56-66. PubMed ID: 21036514
[TBL] [Abstract][Full Text] [Related]
2. In-patient detoxification procedures, treatment retention, and post-treatment opiate use: comparison of lofexidine + naloxone, lofexidine + placebo, and methadone.
McCambridge J; Gossop M; Beswick T; Best D; Bearn J; Rees S; Strang J
Drug Alcohol Depend; 2007 Apr; 88(1):91-5. PubMed ID: 17064857
[TBL] [Abstract][Full Text] [Related]
3. A comparison of buprenorphine and lofexidine for community opiate detoxification: results from a randomized controlled trial.
Raistrick D; West D; Finnegan O; Thistlethwaite G; Brearley R; Banbery J
Addiction; 2005 Dec; 100(12):1860-7. PubMed ID: 16367987
[TBL] [Abstract][Full Text] [Related]
4. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
[TBL] [Abstract][Full Text] [Related]
5. Outpatient opiate detoxification with clonidine.
Washton AM; Resnick RB
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):39-41. PubMed ID: 7085584
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
7. Controlled trial of prescribed heroin in the treatment of opioid addiction.
March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
9. The clinical use of clonidine in outpatient detoxification from opiates.
Washton AM; Resnick RB
Prog Clin Biol Res; 1981; 71():277-84. PubMed ID: 7330080
[No Abstract] [Full Text] [Related]
10. Buprenorphine for acute heroin detoxification: diffusion of research into practice.
Kovas AE; McFarland BH; McCarty DJ; Boverman JF; Thayer JA
J Subst Abuse Treat; 2007 Mar; 32(2):199-206. PubMed ID: 17306728
[TBL] [Abstract][Full Text] [Related]
11. Quality of life under maintenance treatment with heroin versus methadone in patients with opioid dependence.
Karow A; Reimer J; Schäfer I; Krausz M; Haasen C; Verthein U
Drug Alcohol Depend; 2010 Dec; 112(3):209-15. PubMed ID: 20728288
[TBL] [Abstract][Full Text] [Related]
12. Use of qigong therapy in the detoxification of heroin addicts.
Li M; Chen K; Mo Z
Altern Ther Health Med; 2002; 8(1):50-4, 56-9. PubMed ID: 11795622
[TBL] [Abstract][Full Text] [Related]
13. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial.
Collins ED; Kleber HD; Whittington RA; Heitler NE
JAMA; 2005 Aug; 294(8):903-13. PubMed ID: 16118380
[TBL] [Abstract][Full Text] [Related]
14. Well-being, psychosocial factors, and side-effects among heroin-dependent inpatients after detoxification using buprenorphine versus clonidine.
Ponizovsky AM; Grinshpoon A; Margolis A; Cohen R; Rosca P
Addict Behav; 2006 Nov; 31(11):2002-13. PubMed ID: 16524668
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine/naloxone versus methadone and lofexidine in community stabilisation and detoxification: A randomised controlled trial of low dose short-term opiate-dependent individuals.
Law FD; Diaper AM; Melichar JK; Coulton S; Nutt DJ; Myles JS
J Psychopharmacol; 2017 Aug; 31(8):1046-1055. PubMed ID: 28631527
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine and methadone: a comparison of patient completion rates during inpatient detoxification.
Blondell RD; Smith SJ; Servoss TJ; DeVaul SK; Simons RL
J Addict Dis; 2007; 26(2):3-11. PubMed ID: 17594993
[TBL] [Abstract][Full Text] [Related]
17. Short-term outcomes of five heroin detoxification methods in the Australian NEPOD Project.
Digiusto E; Lintzeris N; Breen C; Kimber J; Mattick RP; Bell J; Ali R; Saunders JB;
Addict Behav; 2005 Mar; 30(3):443-56. PubMed ID: 15718062
[TBL] [Abstract][Full Text] [Related]
18. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
[TBL] [Abstract][Full Text] [Related]
19. Physical and mental health in severe opioid-dependent patients within a randomized controlled maintenance treatment trial.
Reimer J; Verthein U; Karow A; Schäfer I; Naber D; Haasen C
Addiction; 2011 Sep; 106(9):1647-55. PubMed ID: 21489005
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: findings of the German randomized controlled trial.
Eiroa-Orosa FJ; Haasen C; Verthein U; Dilg C; Schäfer I; Reimer J
Drug Alcohol Depend; 2010 Dec; 112(3):226-33. PubMed ID: 20708349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]